Abstract: 【Abstract】Chronic kidney disease-mineral and bone disorder (CKD-MBD) is one of the common complications in patients with chronic kidney disease (CKD), and the control of hyperphosphatemia is the key to the prevention and treatment of CKD- MBD. However, drugs are often overlooked as the potential sources of phosphorus burden in patients with chronic kidney disease. Therefore, the research progresses in phosphate content of drugs, low dietary phosphorus to protein ratio are reviewed in this article.

Key words: Phosphate content in drug, Low dietary phosphorus to protein ratio, Chronic kidney disease - mineral and bone disorder